Table 1.
Demographic and clinical data and between-group comparisons for the healthy control (HC) and schizophrenia patient (SZ) groups.
| HC (N = 16) | SZ (N = 23) | Statistic | p | |
|---|---|---|---|---|
| Age (years) | 41.3 ± 5.0 | 42 ± 9.6 | t(37) = −0.26 | 0.81 |
| Parental socioeconomic status | 2.6 ± 1.1 | 2.6 ± 1.0 | t(37) = 0.05 | 0.96 |
| WRAT-3 | 49.31 ± 5.52 | 47.64 ± 4.61 | t(36) = 0.988 | 0.33 |
| Age of onset (years) | 24.3 ± 6.6 | |||
| Positive symptom total (SAPS) | 9.4 ± 3.4 | |||
| Negative symptom total (SANS) | 10.5 ± 6.2 | |||
| Medication dosage (chlorpromazine equivalent) | 365.8 ± 379.6 | |||
| Range: 100–1467 |
Mean ± SD are given for each variable.
WRAT-3, Wide Range Achievement Test; SAPS, Scale for the Assessment of Positive Symptoms; SANS, Scale for the Assessment of Negative Symptoms.